Metabolic engineering for the high-yield production of isoprenoid-based C5 alcohols in E. coli
Article 2015 en
Authors
KG
Kevin W. George
MT
Mitchell G. Thompson
AK
Aram Kang
Abstract
1 min read
Abstract Branched five carbon (C 5 ) alcohols are attractive targets for microbial production due to their desirable fuel properties and importance as platform chemicals. In this study, we engineered a heterologous isoprenoid pathway in E. coli for the high-yield production of 3-methyl-3-buten-1-ol, 3-methyl-2-buten-1-ol and 3-methyl-1-butanol, three C 5 alcohols that serve as potential biofuels. We first constructed a pathway for 3-methyl-3-buten-1-ol, where metabolite profiling identified NudB, a promiscuous phosphatase, as a likely pathway bottleneck. We achieved a 60% increase in the yield of 3-methyl-3-buten-1-ol by engineering the Shine-Dalgarno sequence of nudB , which increased protein levels by 9-fold and reduced isopentenyl diphosphate (IPP) accumulation by 4-fold. To further optimize the pathway, we adjusted mevalonate kinase (MK) expression and investigated MK enzymes from alternative microbes such as Methanosarcina mazei . Next, we expressed a fusion protein of IPP isomerase and the phosphatase (Idi1~NudB) along with a reductase (NemA) to diversify production to 3-methyl-2-buten-1-ol and 3-methyl-1-butanol. Finally, we used an oleyl alcohol overlay to improve alcohol recovery, achieving final titers of 2.23 g/L of 3-methyl-3-buten-1-ol (~70% of pathway-dependent theoretical yield), 150 mg/L of 3-methyl-2-buten-1-ol and 300 mg/L of 3-methyl-1-butanol.
Leo d’Espaux, Amit Ghosh, Weerawat Runguphan, Maren Wehrs, Feng Xu, Oliver Konzock, Ishaan Dev, Melissa Nhan, Jennifer Gin, Amanda Reider Apel, Christopher J. Petzold, Seema Singh, Blake A. Simmons, Aindrila Mukhopadhyay, Héctor García Martín, Jay D Keasling
Qingyun Dan, Yan Chiu, Namil Lee, J.H. Pereira, Xixi Zhao, Chunjun Zhan, Yinghui Rong, Yan Chen, Seokjung Cheong, Chenyi Li, Jennifer Gin, Andria V. Rodrigues, Tyler W. H. Backman, Edward E. K. Baidoo, Christopher J. Petzold, Paul D. Adams, Jay D Keasling
Discussion(0)
No comments yet. Be the first to comment.